Pluristem Therapeutics (PSTI)'s Ohad Karnieli To Deliver A Plenary Presentation On Cell Therapy Manufacturing At ISUS 2014 Conference
6/30/2014 8:04:48 AM
HAIFA, Israel, June 30, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, today announced its VP of Development & Manufacturing, Ohad Karnieli, Ph.D., will give a plenary talk at the Bio-Process Systems Alliance's (BPSA) 4th Annual International Single-Use Summit (ISUS 2014), which will be held on July 9-11, 2014 in Washington, D.C.
Help employers find you! Check out all the jobs and post your resume.
comments powered by